Inventor
MAGNUSON STEVEN R
US25 patents
⚠️ This page may combine multiple inventors who share the name “MAGNUSON STEVEN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
12 patentsUS10308614B2Jun 4, 2019
Therapeutic compounds and uses thereof
GENENTECH INC4 citations73
US10183009B2Jan 22, 2019
Therapeutic compounds and uses thereof
GENENTECH INC3 citations72
US9505767B2Nov 29, 2016
Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors
GENENTECH INC4 citations72
US10206931B2Feb 19, 2019
Therapeutic compounds and uses thereof
GENENTECH INC5 citations71
US9382241B2Jul 5, 2016
Aminoquinazoline and pyridopyrimidine derivatives
GENENTECH INC2 citations61
US10150767B2Dec 11, 2018
Therapeutic compounds and uses thereof
GENENTECH INC1 citations50
US9592235B2Mar 14, 2017
Aminoquinazoline and pyridopyrimidine derivatives
GENENTECH INC0 citations50
US9434732B2Sep 6, 2016
Triazolopyridine JAK inhibitor compounds and methods
GENENTECH INC1 citations48
US9855269B2Jan 2, 2018
Aminoquinazoline and pyridopyrimidine derivatives
GENENTECH INC0 citations47
US10202378B2Feb 12, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US9586956B2Mar 7, 2017
Isoquinoline and naphthyridine derivatives
GENENTECH INC0 citations41
US10258603B2Apr 16, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations40
BAYER PHARMACEUTICALS CORP
5 patentsUS6660752B2Dec 9, 2003
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP24 citations92
US6900205B2May 31, 2005
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
BAYER PHARMACEUTICALS CORP19 citations90
US7109196B2Sep 19, 2006
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
BAYER PHARMACEUTICALS CORP7 citations71
US6699860B2Mar 2, 2004
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP8 citations71
US6919371B2Jul 19, 2005
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP2 citations62